Authorized Generics Study From FTC To Be Released Shortly

FTC’s analysis of the competitive impact of authorized generics may be issued this month, just as a possible legislative vehicle for changes – a bill to ban “reverse payment” settlements – is gathering speed.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet